FDA label expansion for UCB’s Cimzia
The FDA has approved the drug for a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis.
Read More
Tag: The U.S. Food and Drug Administration
FDA rejects oral Type I diabetes drug
The FDA has dashed Sanofi’s hopes of launching its type I diabetes drug, Zynquista, this year.
Read More
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
